4552 Stock Overview
Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4552 from our risk checks.
JCR Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥665.00 |
| 52 Week High | JP¥1,567.00 |
| 52 Week Low | JP¥466.00 |
| Beta | 0.056 |
| 11 Month Change | 24.30% |
| 3 Month Change | 14.85% |
| 1 Year Change | -45.74% |
| 33 Year Change | -77.77% |
| 5 Year Change | -64.72% |
| Change since IPO | 198.88% |
Recent News & Updates
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Sep 06
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You
Sep 04JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Aug 23JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Aug 09Recent updates
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Sep 06What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You
Sep 04JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Aug 23JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Aug 09Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts
Aug 03JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00
Jul 26JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Jul 12JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
May 22JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Mar 18JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Feb 29Shareholder Returns
| 4552 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 6.2% | -6.0% | -4.0% |
| 1Y | -45.7% | 14.5% | 8.8% |
Return vs Industry: 4552 underperformed the JP Pharmaceuticals industry which returned 14.5% over the past year.
Return vs Market: 4552 underperformed the JP Market which returned 8.8% over the past year.
Price Volatility
| 4552 volatility | |
|---|---|
| 4552 Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.2% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 4552's share price has been volatile over the past 3 months.
Volatility Over Time: 4552's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 934 | Shin Ashida | www.jcrpharm.co.jp |
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease.
JCR Pharmaceuticals Co., Ltd. Fundamentals Summary
| 4552 fundamental statistics | |
|---|---|
| Market cap | JP¥83.01b |
| Earnings (TTM) | JP¥4.10b |
| Revenue (TTM) | JP¥40.21b |
20.3x
P/E Ratio2.1x
P/S RatioIs 4552 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4552 income statement (TTM) | |
|---|---|
| Revenue | JP¥40.21b |
| Cost of Revenue | JP¥10.33b |
| Gross Profit | JP¥29.88b |
| Other Expenses | JP¥25.78b |
| Earnings | JP¥4.10b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 32.83 |
| Gross Margin | 74.31% |
| Net Profit Margin | 10.19% |
| Debt/Equity Ratio | 50.7% |
How did 4552 perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield61%
Payout RatioDoes 4552 pay a reliable dividends?
See 4552 dividend history and benchmarks| JCR Pharmaceuticals dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 09 2024 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 91 days |
Does 4552 pay a reliable dividends?
See 4552 dividend history and benchmarks